What is AvoMD?
AvoMD operates as a sophisticated AI platform designed to empower healthcare enterprises by embedding trusted clinical knowledge directly into the point of care. The company's core technology functions as a clinical copilot, seamlessly processing medical guidelines, payer-specific data, and patient information within existing Electronic Health Record (EHR) systems. By transforming static EHRs into dynamic systems of action, AvoMD facilitates automated workflows across critical areas such as clinical documentation, discharge planning, and order management. This approach not only enhances the quality of patient outcomes but also significantly reduces the administrative burden on clinicians, effectively bridging the gap between complex medical data and actionable bedside intelligence.
How much funding has AvoMD raised?
AvoMD has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2026): $10M with participation from Las Olas VC, AlleyCorp companies, Noro-Moseley Partners, and Medmountain Ventures
Key Investors in AvoMD
Las Olas VC
Las Olas Venture Capital is a venture capital firm that focuses on backing founders who are developing AI and software applications aimed at modernizing outdated business workflows.
AlleyCorp companies
AlleyCorp is a company that focuses on building and investing in transformative businesses, comprised of tech pioneers and entrepreneurs dedicated to creating impactful solutions.
Noro-Moseley Partners
Noro-Moseley Partners specializes in early growth equity investments for rapidly-scaling B2B technology and healthcare companies, focusing on sustainable economic models.
What's next for AvoMD?
Looking ahead, the strategic deployment of this recent investment will likely focus on scaling AvoMD's enterprise-grade infrastructure to support broader adoption across diverse healthcare systems. As the company moves beyond its initial growth phase, the focus will shift toward deepening its integration capabilities and expanding its library of clinical decision support modules. By leveraging the expertise of its investor base, AvoMD is expected to prioritize market penetration and the continuous optimization of its AI models to ensure they remain at the forefront of clinical efficiency. The company's roadmap suggests a commitment to long-term sustainability, aiming to redefine how healthcare organizations manage information and improve operational productivity in an increasingly data-driven medical landscape.
See full AvoMD company page
